Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 2025 of 46697 entries
View as:
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 20
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 6
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 17
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| AltaMed Health Services Corporation | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AltaMed Health Services Corporation.temp.org | 2025-07-14 |
| AltaRex | - | 2 | 0.0% | 0 | 0 | 0.0% | - | AltaRex.temp.org | 2025-07-14 |
| Altaco XXI, LLP | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Altaco XXI, LLP.temp.org | 2025-07-14 |
| Altacor Ltd. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Altacor Ltd..temp.org | 2025-07-14 |
| Altair Therapeutics, Inc. | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Altair Therapeutics, Inc..temp.org | 2025-07-14 |
| Altamash Institute of Dental Medicine | - | 20 | 0.0% | 0 | 0 | 0.0% | - | Altamash Institute of Dental Medicine.temp.org | 2025-07-14 |
| Altamira Medica Ltd. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Altamira Medica Ltd..temp.org | 2025-07-14 |
| Altasciences Company Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Altasciences Company Inc..temp.org | 2025-07-14 |
| Altavant Sciences GmbH | - | 6 | 0.0% | 0 | 0 | 0.0% | - | Altavant Sciences GmbH.temp.org | 2025-07-14 |
| Altea Therapeutics | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Altea Therapeutics.temp.org | 2025-07-14 |
| Altec Inc. | - | 5 | 0.0% | 0 | 0 | 0.0% | - | Altec Inc..temp.org | 2025-07-14 |
| Alteco Medical AB | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Alteco Medical AB.temp.org | 2025-07-14 |
| Alteogen, Inc. | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Alteogen, Inc..temp.org | 2025-07-14 |
| Alter Farmacia, S.A. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alter Farmacia, S.A..temp.org | 2025-07-14 |
| Alterity Therapeutics | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Alterity Therapeutics.temp.org | 2025-07-14 |
| Alterman, Modi, & Wolter Ophthalmic Physicians & Surgeons | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Alterman, Modi, & Wolter Ophthalmic Physicians & Surgeons.temp.org | 2025-07-14 |
| Alternativa International S.A | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alternativa International S.A.temp.org | 2025-07-14 |
| Alternative Research Initiative | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alternative Research Initiative.temp.org | 2025-07-14 |
| Alternative Urological Catheter Systems Ltd. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alternative Urological Catheter Systems Ltd..temp.org | 2025-07-14 |
| Alternatives For Girls | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Alternatives For Girls.temp.org | 2025-07-14 |
| Alterome Therapeutics, Inc. | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Alterome Therapeutics, Inc..temp.org | 2025-07-14 |
| Altesa Biosciences, Inc. | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Altesa Biosciences, Inc..temp.org | 2025-07-14 |
| Althaia Xarxa Assistencial Universitària de Manresa | - | 17 | 0.0% | 0 | 0 | 0.0% | - | Althaia Xarxa Assistencial Universitària de Manresa.temp.org | 2025-07-14 |
| AltheaDx | - | 4 | 0.0% | 0 | 0 | 0.0% | - | AltheaDx.temp.org | 2025-07-14 |
| Altheia Science | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Altheia Science.temp.org | 2025-07-14 |